# MSC-Exosome Therapy for Frontotemporal Dementia

> clinical trial · VERIFIED · 2026-07-13

Status: NOT_YET_RECRUITING · Sponsor: Ruijin Hospital · Condition: Frontotemporal Dementia

- Company: Ruijin Hospital
- Sector: biotech
- Primary source: https://clinicaltrials.gov/study/NCT07638813

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.